Deep Phenotyping in the -Omic Era: Methodological Issues Facing Neuropsychiatric Disorders-Journal of Psychiatry and Brain Science-CSCIED科技核心评价数据库-手机版

Deep Phenotyping in the -Omic Era: Methodological Issues Facing Neuropsychiatric Disorders

Deep Phenotyping in the -Omic Era: Methodological Issues Facing Neuropsychiatric Disorders

ES评分 0 浏览量：668 下载量：0

DOI	10.20900/jpbs.20180011
刊名	Journal of Psychiatry and Brain Science JPBS
年，卷(期)	2018, 3(6)
作者	Gene S. Fisch*,
作者单位	Paul Chook Department of Information Systems & Statistics, CUNY/Baruch College, 1 Bernard Baruch Way, New York, NY 10010, USA.
基金项目
页码	-

参考文献
相关文献

1.Johannsen W. The genotype conception of heredity. Am Nat. 1911; 45: 129-159.

2.Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science. 2008; 322: 881-888.

3.Hennekam RC, Biesecker LG. Next-generation sequencing demands next-generation phenotyping. Hum Mutat. 2012; 33: 884-886.

4.Geschwind DH, Konopka G. Neuroscience in the era of functional genomics and systems biology. Nature. 2009; 461(7266): 908-915.

5.Behjati S, Tarpey PS. What is next generation sequencing? Arch Dis Child Educ Pract Ed. 2013; 98: 236-238.

6.Tracy RP. 'Deep phenotyping': characterizing populations in the era of genomics and systems biology. Curr Opin Lipidol. 2008; 19: 151-157.

7.Joober R. The 1000 Genomes Project: deep genomic sequencing waiting for deep psychiatric phenotyping. J Psychiatry Neurosci. 2011; 36: 147-149.

8.Haring R, Wallaschofski H. Diving through the "-omics": the case for deep phenotyping and systems epidemiology. OMICS. 2012; 16: 231-234.

9.Fisch GS. Whither the genotype-phenotype relationship? An historical and methodological appraisal. Am J Med Genet. 2017; 175C: 343-353.

10.Sydenham T. Observationes Medicae. 3rd ed. London (UK): Typis A. C. Impensis Gualteri Kettilby; 1676.

11.de Sauvages FB. Nosologia Methodica, Scientific illnesses Classes, Genera, Species (1763) (French). Whitefish (US): Kessinger Publishing, LLC; 2009.

12.World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-10). Geneva: World Health Organization; 2008.

13.American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.

14.Carey JC, Allanson JE, Hennekam RC, Biesecker LG. Standard terminology for phenotypic variations: the elements of morphology project, its current progress, and future directions. Hum Mutat. 2012; 33: 781-786.

15.Allanson JE, Cunniff C, Hoyme HE, McGaughran J, Muenke M, Neri G. Elements of morphology: standard of terminology for the head and face. Am J Med Genet Part A. 2009; 149A: 6-28.

16.Biesecker LG, Aase JM, Clericuzio C, Gurrieri F, Temple IK, Toriello H. Elements of morphology: standard terminology for the hands and feet. Am J Med Genet Part A. 2009; 149A: 93-127.

17.Hall BD, Graham JM Jr, Cassidy SB, Opitz JM. Elements of morphology: standard terminology for the periorbital region. Am J Med Genet Part A. 2009; 149A: 29-39.

18.Carey JC, Cohen MM Jr, Curry CJR, Devriendt K, Holmes LB, Verloes A. Elements of morphology: standard terminology for the lips, mouth, and oral region. Am J Med Genet Part A. 2009; 149A: 77-92.

19.Hennekam RCM, Cormier-Daire V, Hall J, M´ehes K, Patton M, Stevenson R. Elements of morphology: standard terminology for the nose and philtrum. Am J Med Genet Part A. 2009; 149A: 61-76.

20.Hunter AG, Frias J, Gillessen-Kaesback G, Hughes H, Jone K, Wilson L. Elements of morphology: standard terminology for the ear. Am J Med Genet Part A. 2009; 149A: 40-60.

21.Carey JC. Phenotype analysis of congenital and neurodevelopmental disorders in the next generation sequencing era. Am J Med Genet C. 2017; 175: 320-328.

22.Cotton RG, Auerbach AD, Axton M, Barash CI, Berkovic SF, Brookes AJ, et al. The Human Variome Project. Science. 2008; 322(5903): 861-862.

23.Robinson PN. Deep phenotyping for precision medicine. Hum Mutat. 2012; 33: 777-780.

24.Köhler S, Vasilevsky NA, Engelstad M, Foster E, McMurry J, Aymé S, et al. The Human Phenotype Ontology in 2017. Nucleic Acids Res. 2017; 45(D1): D865-D876.

25.Köhler S, Schulz MH, Krawitz P, Bauer S, Dölken S, Ott CE, et al. Clinical diagnostics in human genetics with semantic similarity searches in ontologies. Am J Hum Genet. 2009; 85: 457-464.

26.Robinson PN, Köhler S, Bauer S, Seelow D, Horn D, Mundlos S. The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet. 2008; 83: 610-615.

27.Robinson PN, Mungall CJ, Haendel M. Capturing phenotypes for precision medicine. Cold Spring Harb Mol Case Stud. 2015; 1(1): a000372.

28.Frey LJ, Lenert L, Lopez-Campos G. EHR Big Data Deep Phenotyping. Contribution of the IMIA Genomic Medicine Working Group. Yearb Med Inform. 2014; 9: 206-211.

29.Chawes BL, Bønnelykke K, Jensen PF, Schoos AM, Heickendorff L, Bisgaard H. Cord blood 25(OH)-vitamin D deficiency and childhood asthma, allergy and eczema: the COPSAC2000 birth cohort study. PLoS One. 2014; 9(6): e99856.

30.Banerjee P, Choi B, Shahine LK, Jun SH, O'Leary K, Lathi RB, et al. Deep phenotyping to predict live birth outcomes in in vitro fertilization. Proc Natl Acad Sci U S A. 2010; 107: 13570-13575.

31.Alexandrov V, Brunner D, Menalled LB, Kudwa A, Watson-Johnson J, Mazzella M, et al. Large-scale phenome analysis defines a behavioral signature for Huntington's disease genotype in mice. Nat Biotechnol. 2016; 34: 838-844.

32.Ruderfer DM, Dudley JT. Deep phenotyping predicts Huntington's genotype. Nat Biotechnol. 2016; 34: 823-824.

33.Wright S. Correlation and causation. J Agric Res. 1921; 20: 521, 557-585.

34.Kohane IS, Masys DR, Altman RB. The incidentalome: a threat to genomic medicine. JAMA. 2006; 296: 212-215.

35.Kohane IS, Hsing M, Kong SW. Taxonomizing, sizing, and overcoming the incidentalome. Genet Med. 2012; 14: 399-404.

36.Austin PC, Mamdani MM, Juurlink DN, Hux JE. Testing multiple statistical hypotheses resulted in spurious associations: a study of astrological signs and health. J Clin Epidemiol. 2006; 59: 964-969.

37.Blakesley RE, Mazumdar S, Dew MA, Houck PR, Tang G, Reynolds CF 3rd, et al. Comparisons of methods for multiple hypothesis testing in neuropsychological research. Neuropsychology. 2009; 23: 255-264.

38.Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995; 57: 289-300.

39.Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001; 125: 279-284.

40.Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003; 100: 9440-9445.

41.Käll L, Storey JD, MacCoss MJ, Noble WS. Posterior error probabilities and false discovery rates: two sides of the same coin. J Proteome Res. 2008; 7: 40-44.

42.Gamazon ER, Huang RS, Dolan ME, Cox NJ, Im HK. Integrative genomics: quantifying significance of phenotype-genotype relationships from multiple sources of high-throughput data. Front Genet. 2013; 3: 202.

43.van den Oord EJ. Controlling false discoveries in genetic studies. Am J Med Genet B 2008; 147B(5): 637-644.

44.Jager LR, Leek JT. An estimate of the science-wise false discovery rate and application to the top medical literature. Biostatistics. 2014; 15: 1-12.

45.Benjamini Y, Hechtlinger Y. Discussion: An estimate of the science-wise false discovery rate and applications to top medical journals by Jager and Leek. Biostatistics. 2014; 15: 13-16.

46.Ioannidis JP. Discussion: Why "An estimate of the science-wise false discovery rate and application to the top medical literature" is false. Biostatistics. 2014; 15: 28-36, discussion 39-45.

47.Human phenotype ontology. Available online: https://hpo.jax.org/app/ (accessed on 28 Nov 2018).

48.Holland PW. Statistics and Causal Inference. J Am Stat Assoc. 1986; 81(396): 945-960.

49.Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR; International Huntington's Disease Collaborative Group. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet. 2004; 65: 267-277.

50.Feiglin A, Allen BK, Kohane IS, Kong SW. Comprehensive Analysis of Tissue-wide Gene Expression and Phenotype Data Reveals Tissues Affected in Rare Genetic Disorders. Cell Syst. 2017; 5: 140-148.

51.Jackson R, Patel R, Velupillai S, Gkotsis G, Hoyle D, Stewart R. Knowledge discovery for Deep Phenotyping serious mental illness from Electronic Mental Health records. F1000Res. 2018; 7: 210.

52.Son JH, Xie G, Yuan C, Ena L, Li Z, Goldstein A, Huang L, et al. Deep Phenotyping on Electronic Health Records Facilitates Genetic Diagnosis by Clinical Exomes. Am J Hum Genet. 2018; 103: 58-73.

53.Hripcsak G, Albers DJ. Correlating electronic health record concepts with healthcare process events. J Am Med Inform Assoc. 2013; 20(e2): e311-e318.

54.Kendler K. Toward a scientific psychiatric nosology. Strengths and limitations. Arch Gen Psychiatry. 1990; 47: 969-973.

55.Kendler K. Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am J Psychiatry. 2006; 163: 1138-1146.

56.American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Arlington, VA: American Psychiatric Association; 1980.

57.American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Revised. Arlington, VA: American Psychiatric Association; 1987.

58.Fisch GS. Nosology and epidemiology in autism: Classification counts. Am J Med Genet C. 2012; 160C: 91-103.

59.Polderman TJ, Benyamin B, de Leeuw CA, Sullivan PF, van Bochoven A, Visscher PM, et al. Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet. 2015; 47(7): 702-709.

60.Geschwind DH. Autism: Many genes, common pathways? Cell. 2008; 135: 391-395.

61.Szatmari P, Maziade M, Zwaigenbaum L, Mérette C, Roy MA, Joober R, et al. Informative phenotypes for genetic studies of psychiatric disorders. Am J Med Genet Part B. 2007; 144B: 581-588.

62.Stepniak B, Papiol S, Hammer C, Ramin A, Everts S, Hennig L, et al. Accumulated environmental risk determining age at schizophrenia onset: a deep phenotyping-based study. Lancet Psychiatry. 2014; 1: 444-453.

63.Gottesman II, Shields J. Genetic theorizing and schizophrenia. Br J Psychiatry. 1973; 122: 15-30.

64.Cox DR, Wermuth N. Causality: A statistical view. Int Stat Rev. 2004; 72: 285-305.

引用本文

Gene S. Fisch*. Deep Phenotyping in the -Omic Era: Methodological Issues Facing Neuropsychiatric Disorders, Journal of Psychiatry and Brain Science. 2018; 3; (6). https://doi.org/10.20900/jpbs.20180011.

文献评论

相关学者

相关机构